Runda Medical's March 31st large block trade involved a total transaction amount of 7.54 million yuan, with a premium rate of -8.16%.

robot
Abstract generation in progress

When trading stocks, just follow the Golden Qilin analyst research reports—authoritative, professional, timely, comprehensive—helping you uncover high-potential theme opportunities!

On March 31, RunDa Medical fell by 1.79%, closing at 12.63 yuan. There was 1 block trade, with a total traded volume of 650k shares and a transaction amount of 7.54 million yuan.

The first trade price was 11.60 yuan, with 650.00 thousand shares and a transaction amount of 7.54 million yuan. The premium rate was -8.16%. The buyer’s business department was the Guotai Huarong Securities Co., Ltd. Shanghai Changning District Tianshan West Road securities business department. The seller’s business department was the China Securities Construction Investment Securities Co., Ltd. Hangzhou Qingchun Road securities business department.

Further statistics show that over the past 3 months, this stock has had a total of 5 block trades, with a combined transaction amount of 650k yuan. Over the past 5 trading days, the stock has cumulatively fallen by 2.70%, and the main fund has cumulatively recorded net outflows of 44.5178 million yuan.

Statement: The market involves risk; investment requires caution. This article is automatically published based on a third-party database and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are any discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise analysis—right on the Sina Finance app

责任编辑:小浪快报

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments